Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Dual TLR7 and TLR9 antagonist has therapeutic effects in mouse model of atherosclerosis

April 27, 2010

EMD-1214063 displays potent and selective c-Met inhibition

April 27, 2010

Updated phase I data disclosed on IMO-2125 in HCV infection

April 27, 2010

INT-747 promising as add-on therapy to ursodeoxycholic acid for primary biliary cirrhosis

April 27, 2010

Hepatitis C treatment SCY-635 associated with a high barrier to resistance

April 27, 2010

Humoral responses to DC-Melvac cancer vaccine seen in melanoma patients

April 27, 2010

Preclinical data support virodhamine as potential antifibrogenic mediator

April 26, 2010

XL-647/sorafenib combination shows promise in preclinical models of HCC

April 26, 2010

BATTLE trial identifies biomarkers for personalized lung cancer therapy

April 26, 2010

Clinical data presented from several GS-9450 studies

April 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...